Company / Cash per Share
Catalyst Pharmaceuticals Partners, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$5.79
FY2025
5-year range
$1.28 / $5.79
FY2021-FY2025
Trend
+35.2%
vs FY2024
Sector context
#32 of 204
Health Care
What the data says
Catalyst Pharmaceuticals Partners, Inc.'s cash per share of $5.79 is higher than 84% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 10 years, ranging from $0.16 in FY2018 to $5.79 in FY2025.
Based on SEC 10-K filings.
5.79 in FY2025 with a 5-year CAGR of +35.7%. Top quartile in the Health Care sector.
Improved from $1.28 to $5.79 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +26.9%
- 5-Year CAGR
- +35.7%
- 10-Year CAGR
- -
Sector benchmark
-92.1% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 35.2% year-over-year.
- Ranks #32 out of 204 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.79 | +35.2% |
| FY2024 | $4.28 | +233.2% |
| FY2023 | $1.28 | -54.7% |
| FY2022 | $2.83 | +70.3% |
| FY2021 | $1.66 | +32.2% |
| FY2020 | $1.26 | +44.6% |
| FY2019 | $0.87 | +439.6% |
| FY2018 | $0.16 | -3.6% |
| FY2017 | $0.17 | +0.0% |
| FY2016 | $0.17 | -50.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026